Given the immune responses and inflammation associated with irritable bowel syndrome (IBS), our hypothesis focuses on the LPS-activated NF-κB pathway in our cellular model, highlighting its pivotal role in regulating AQP8 expression in the context of IBS. Here, NFKB1 is linked to irritable bowel syndrome.